Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
630.00    30.00 (5.00%)
Bid:
626.00
Ask:
634.00
Spread: 8.00 (1.278%)
Market Cap: £762.36m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

Block Listing Return

4 Jan 2021 14:09

RNS Number : 4792K
Oxford Biomedica PLC
04 January 2021
 

For Immediate Release

04 January 2021

 

OXFORD BIOMEDICA PLC

 

BLOCK LISTING RETURN

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

1 July 2020

To:

31 December 2020

Balance of unallotted securities under scheme(s) from previous return:

173,014

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

200,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

159,816

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

213,198

     

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Long Term Incentive Plan

Period of return:

From:

1 July 2020

To:

31 December 2020

Balance of unallotted securities under scheme(s) from previous return:

211,739

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

31,979

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

179,760

     

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Deferred Bonus Plan

Period of return:

From:

1 July 2020

To:

31 December 2020

Balance of unallotted securities under scheme(s) from previous return:

85,644

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

100,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

29,965

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

155,679

     

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Sharesave Scheme

Period of return:

From:

1 July 2020

To:

31 December 2020

Balance of unallotted securities under scheme(s) from previous return:

292,180

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

51,829

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

240,351

     

 

Name of contact:

Natalie Walter

Telephone number of contact:

01865 783000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRBIMITMTMMBIB
Date   Source Headline
3rd Jan 202311:28 amRNSTotal Voting Rights
21st Dec 202212:00 pmRNSOxford Biomedica to Present at J.P Morgan
14th Dec 20227:00 amRNSOxford Biomedica Solutions forms new partnerships
22nd Nov 20227:00 amRNSOxford Biomedica Appoints Frank Mathias as CEO
15th Nov 20222:35 pmRNSHolding(s) in Company
14th Nov 20227:00 amRNSSale and leaseback of Windrush Court facility
1st Nov 20229:14 amRNSTotal Voting Rights
14th Oct 20222:28 pmRNSPDMR Dealings
12th Oct 20227:00 amRNSPDMR Dealings
12th Oct 20227:00 amRNSPDMR Dealings
7th Oct 20221:16 pmRNSPDMR Dealing Amendment
7th Oct 202212:28 pmRNSPDMR Dealing
7th Oct 20227:00 amRNSAmendment of Short-Term Loan Facility
3rd Oct 20229:34 amRNSTotal Voting Rights
15th Sep 20227:00 amRNSInterim Results
14th Sep 20227:00 amRNSOxford Biomedica Solutions signs new partner
7th Sep 20227:00 amRNSLicence & Supply Agreement with New Partner
1st Sep 20229:51 amRNSTotal Voting Rights
25th Aug 20227:00 amRNSNotice of Interim Results
16th Aug 20227:00 amRNSOxford Biomedica Notes Homology Q2 Report
1st Aug 20229:42 amRNSTotal Voting Rights
27th Jul 20227:00 amRNSAppointment of Joint Corporate Broker
26th Jul 20227:00 amRNSLicence & Supply Agreement with New Partner
26th Jul 20227:00 amRNSNew Project with Orchard Therapeutics
21st Jul 20227:00 amRNSExpanded Agreement with BMS’s Juno in CAR-T
15th Jul 202210:13 amRNSBLOCK LISTING RETURN
1st Jul 20229:55 amRNSTotal Voting Rights
1st Jul 20227:00 amRNSSigns new agreement with AstraZeneca
14th Jun 20227:00 amRNSNotes FDA lift clinical hold on pheNIX trial
1st Jun 20227:00 amRNSTotal Voting Rights
27th May 20226:03 pmRNSResult of AGM
3rd May 20225:18 pmRNSGrant of options
3rd May 20224:46 pmRNSDirector/PDMR Shareholding
3rd May 202210:35 amRNSTotal Voting Rights
29th Apr 20225:42 pmRNSDirectors Dealings / Market Share Purchases
28th Apr 20222:24 pmRNSDirector/PDMR Shareholding
27th Apr 20222:58 pmRNS2021 Annual report and accounts & AGM notification
27th Apr 202212:10 pmRNSPDMR Dealings / Market Share Purchase
21st Apr 20224:41 pmRNSDirector Share Purchase
21st Apr 20221:24 pmRNSDirectors Dealings / Market Share Purchase
21st Apr 202210:16 amRNSDirector/PDMR Shareholding
20th Apr 20223:45 pmRNSDirector/PDMR Shareholding
20th Apr 20227:00 amRNSPreliminary Results
13th Apr 20227:00 amRNSBoard Appointment
4th Apr 202211:34 amRNSNotice of Preliminary Results
1st Apr 20226:30 pmRNSHolding(s) in Company
1st Apr 202210:33 amRNSBlock listing Application
1st Apr 20229:34 amRNSTotal Voting Rights
31st Mar 20226:07 pmRNSHolding(s) in Company
30th Mar 20221:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.